XML 39 R27.htm IDEA: XBRL DOCUMENT v3.23.3
NATURE OF BUSINESS (Details)
1 Months Ended 12 Months Ended
Nov. 25, 2022
Apr. 20, 2022
shares
Mar. 31, 2022
shares
Nov. 11, 2021
$ / shares
shares
Sep. 03, 2021
USD ($)
Jul. 09, 2021
USD ($)
Dec. 07, 2020
USD ($)
Jun. 30, 2020
shares
Jan. 19, 2017
USD ($)
shares
Jul. 31, 2021
USD ($)
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
Nov. 26, 2022
USD ($)
Nov. 15, 2021
shares
Nov. 04, 2021
Jun. 30, 2021
USD ($)
Apr. 06, 2021
Feb. 04, 2021
NATURE OF BUSINESS (Details) [Line Items]                                    
Stock Issued During Period, Shares, Acquisitions (in Shares) | shares               510,000,000 16,155,746,000                  
Proceeds from Sales of Business, Affiliate and Productive Assets                 $ 100                  
Payments to Acquire Investments           $ 50,000                        
Number of Units in Real Estate Property         53                          
Number of Real Estate Properties         19                          
SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Gross         $ 7,626,286.37                          
Payments to Acquire Real Estate         $ 7,000,000                          
Real Estate, Description of Terms         The purchase price shall be paid as follows: (i) $1,000,000 on execution of the Agreement, (ii) $2,000,000 within 60 days thereof and (iii) the remainder by April 10, 2022. The Agreement is subject to customary closing conditions, including, satisfactory due diligence.                          
Class of Warrant or Rights, Granted (in Shares) | shares       500,000                            
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ / shares       $ 0.01                            
Warrants and Rights Outstanding, Term       24 months                            
Stock Issued During Period, Shares, New Issues (in Shares) | shares   500,000 1,300,000                              
Investment Owned, Balance, Shares (in Shares) | shares                           20,000,000        
Agreement, Description The Company A agrees that if the patent is sold or transferred, Men Hwei, Tsai or Men Hwei, Tsai's successor may receive a 25% gain on the transfer or sale of the interest. The Company agrees to give Men Hwei, Tsai an additional 20 million AAGH shares. The Company allows Men Hwei, Tsai to use three years (from November 26, 2022 to November 25, 2025) find investors each with more than US$10 million investment. In case that no investor is found within three years, Men Hwei, Tsai agrees to return the patent to the Company, and both parties will continue to cooperate in accordance with the original contract on May 18, 2021. If Men Hwei, Tsai finds an investor with an investment of at least US$10 million within three years, and the process for Men Hwei, Tsai and its investors to apply for a new drug may last for several years, then Men Hwei, Tsai agrees that the Company will use the patented technology to develop dietary supplement that are helpful to Alzheimer’s disease. The Company will be responsible for marketing the dietary supplement. Men Hwei, Tsai is entitled to commission equaling to 8% of sales price.                                  
Other Commitment                         $ 34,978.48          
Net Income (Loss) Attributable to Parent                     $ (777,340) $ (4,924,936)            
Net Cash Provided by (Used in) Operating Activities                     (752,902) (1,479,858)            
Equity, Including Portion Attributable to Noncontrolling Interest                     (4,525,836) (3,860,481)       $ (467,827)    
Cash                     $ 54,150 $ 62,643            
Gof Biotechnologies, Inc. [Member]                                    
NATURE OF BUSINESS (Details) [Line Items]                                    
Subsidiary, Ownership Percentage, Parent                           75.00%        
Investment Owned, Balance, Shares (in Shares) | shares                           60,000,000        
Subsidiary, Ownership Percentage, Noncontrolling Owner                           25.00%        
Purecell Group [Member]                                    
NATURE OF BUSINESS (Details) [Line Items]                                    
Equity Method Investment, Ownership Percentage               51.00%     51.00%           51.00%  
JV Company [Member]                                    
NATURE OF BUSINESS (Details) [Line Items]                                    
Equity Method Investment, Ownership Percentage             60.00%                      
Brilliant Healthcare Limited [Member]                                    
NATURE OF BUSINESS (Details) [Line Items]                                    
Equity Method Investment, Ownership Percentage             40.00%                      
Nutrature Health LLC [Member]                                    
NATURE OF BUSINESS (Details) [Line Items]                                    
Equity Method Investment, Ownership Percentage                     100.00%       100.00%      
Gof Biotechnologies, Inc. [Member]                                    
NATURE OF BUSINESS (Details) [Line Items]                                    
Equity Method Investment, Ownership Percentage                           100.00%        
International Institute of Great Health, Inc. (IIGH) [Member]                                    
NATURE OF BUSINESS (Details) [Line Items]                                    
Equity Method Investment, Ownership Percentage                                   100.00%
Corporate Joint Venture [Member]                                    
NATURE OF BUSINESS (Details) [Line Items]                                    
Payments to Acquire Interest in Joint Venture             $ 4,200,000                      
Co-venturer [Member]                                    
NATURE OF BUSINESS (Details) [Line Items]                                    
Investments in and Advances to Affiliates, at Fair Value, Period Increase (Decrease)                   $ 100,000                
Co-venturer [Member] | Common Stock [Member]                                    
NATURE OF BUSINESS (Details) [Line Items]                                    
Payments to Acquire Interest in Joint Venture             15,000,000                      
Co-venturer [Member] | Cash Distribution [Member]                                    
NATURE OF BUSINESS (Details) [Line Items]                                    
Payments to Acquire Interest in Joint Venture             $ 3,000,000